CASP3 and pancreatic neoplasm: None of the pancreatic cancer cell lines treated with CFL1 siRNA showed cleaved-caspase 3 or cleaved PARP activity–both indications for apoptosis - nor did any of the cells treated with non-silencing siRNA or untreated cells.